company background image
HRC

Hill-Rom HoldingsNYSE:HRC Stock Report

Last Price

US$155.96

Market Cap

US$10.3b

7D

0.1%

1Y

65.8%

Updated

13 Dec, 2021

Data

Company Financials +
HRC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance3/6
Financial Health4/6
Dividends0/6

HRC Stock Overview

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide.

Hill-Rom Holdings Competitors

Intuitive Surgical

NasdaqGS:ISRG

US$109.9b

Stryker

NYSE:SYK

US$100.6b

Edwards Lifesciences

NYSE:EW

US$73.8b

ResMed

NYSE:RMD

US$36.9b

Price History & Performance

Summary of all time highs, changes and price drops for Hill-Rom Holdings
Historical stock prices
Current Share PriceUS$155.96
52 Week HighUS$156.22
52 Week LowUS$93.34
Beta0.55
1 Month Change0.58%
3 Month Change3.16%
1 Year Change65.76%
3 Year Change73.42%
5 Year Change183.15%
Change since IPO604.90%

Recent News & Updates

Aug 16
Here's Why We Think Hill-Rom Holdings (NYSE:HRC) Is Well Worth Watching

Here's Why We Think Hill-Rom Holdings (NYSE:HRC) Is Well Worth Watching

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...

Shareholder Returns

HRCUS Medical EquipmentUS Market
7D0.1%-1.2%-0.5%
1Y65.8%3.8%13.7%

Return vs Industry: HRC exceeded the US Medical Equipment industry which returned 15.2% over the past year.

Return vs Market: HRC exceeded the US Market which returned 21% over the past year.

Price Volatility

Is HRC's price volatile compared to industry and market?
HRC volatility
HRC Average Weekly Movement0.9%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.6%
10% most volatile stocks in US Market15.9%
10% least volatile stocks in US Market2.4%

Stable Share Price: HRC is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 1% a week.

Volatility Over Time: HRC's weekly volatility (1%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
191510,000John Groetelaarshttps://www.hillrom.com

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. The company operates through Patient Support Systems, Front Line Care, and Surgical Solutions segments. It offers medical surgical beds, intensive care unit beds, and bariatric patient beds, patient mobility solutions, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment.

Hill-Rom Holdings Fundamentals Summary

How do Hill-Rom Holdings's earnings and revenue compare to its market cap?
HRC fundamental statistics
Market CapUS$10.30b
Earnings (TTM)US$248.50m
Revenue (TTM)US$3.02b

41.5x

P/E Ratio

3.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HRC income statement (TTM)
RevenueUS$3.02b
Cost of RevenueUS$1.43b
Gross ProfitUS$1.59b
ExpensesUS$1.34b
EarningsUS$248.50m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)3.76
Gross Margin52.61%
Net Profit Margin8.23%
Debt/Equity Ratio110.8%

How did HRC perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

25%

Payout Ratio

Does HRC pay a reliable dividends?

See HRC dividend history and benchmarks
When do you need to buy HRC by to receive an upcoming dividend?
Hill-Rom Holdings dividend dates
Ex Dividend DateDec 14 2021
Dividend Pay DateDec 31 2021
Days until Ex dividend35 days
Days until Dividend pay date18 days

Does HRC pay a reliable dividends?

See HRC dividend history and benchmarks

Valuation

Is Hill-Rom Holdings undervalued compared to its fair value and its price relative to the market?

6.8%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: HRC ($155.96) is trading below our estimate of fair value ($167.32)

Significantly Below Fair Value: HRC is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: HRC is good value based on its PE Ratio (41.5x) compared to the US Medical Equipment industry average (47.1x).

PE vs Market: HRC is poor value based on its PE Ratio (41.5x) compared to the US market (17.2x).


Price to Earnings Growth Ratio

PEG Ratio: HRC is poor value based on its PEG Ratio (2x)


Price to Book Ratio

PB vs Industry: HRC is overvalued based on its PB Ratio (5.5x) compared to the US Medical Equipment industry average (3.7x).


Future Growth

How is Hill-Rom Holdings forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

20.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: HRC's forecast earnings growth (20.4% per year) is above the savings rate (2%).

Earnings vs Market: HRC's earnings (20.4% per year) are forecast to grow faster than the US market (13.7% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: HRC's revenue (4.2% per year) is forecast to grow slower than the US market (10% per year).

High Growth Revenue: HRC's revenue (4.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: HRC's Return on Equity is forecast to be low in 3 years time (18.6%).


Past Performance

How has Hill-Rom Holdings performed over the past 5 years?

10.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: HRC has a large one-off loss of $103.9M impacting its September 30 2021 financial results.

Growing Profit Margin: HRC's current net profit margins (8.2%) are higher than last year (7.7%).


Past Earnings Growth Analysis

Earnings Trend: HRC's earnings have grown by 10.6% per year over the past 5 years.

Accelerating Growth: HRC's earnings growth over the past year (11.4%) exceeds its 5-year average (10.6% per year).

Earnings vs Industry: HRC earnings growth over the past year (11.4%) underperformed the Medical Equipment industry 51.2%.


Return on Equity

High ROE: HRC's Return on Equity (13.2%) is considered low.


Financial Health

How is Hill-Rom Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: HRC's short term assets ($1.4B) exceed its short term liabilities ($991.2M).

Long Term Liabilities: HRC's short term assets ($1.4B) do not cover its long term liabilities ($2.1B).


Debt to Equity History and Analysis

Debt Level: HRC's net debt to equity ratio (96.4%) is considered high.

Reducing Debt: HRC's debt to equity ratio has reduced from 173.9% to 110.8% over the past 5 years.

Debt Coverage: HRC's debt is well covered by operating cash flow (22.9%).

Interest Coverage: HRC's interest payments on its debt are well covered by EBIT (7.4x coverage).


Balance Sheet


Dividend

What is Hill-Rom Holdings's current dividend yield, its reliability and sustainability?

0.62%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: HRC's dividend (0.62%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.33%).

High Dividend: HRC's dividend (0.62%) is low compared to the top 25% of dividend payers in the US market (3.58%).


Stability and Growth of Payments

Stable Dividend: HRC is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: HRC is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: HRC is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of HRC's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.3yrs

Average management tenure


CEO

John Groetelaars (54 yo)

3.58yrs

Tenure

US$7,628,308

Compensation

Mr. John P. Groetelaars serves as President, Chief Executive Officer and Director of Hill-Rom Holdings Inc. since May 14, 2018. Mr. Groetelaars served in a variety of progressive roles at C.R. Bard during...


CEO Compensation Analysis

Compensation vs Market: John's total compensation ($USD7.63M) is below average for companies of similar size in the US market ($USD11.15M).

Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: HRC's management team is considered experienced (4.3 years average tenure).


Board Members

Experienced Board: HRC's board of directors are considered experienced (4.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Hill-Rom Holdings, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Hill-Rom Holdings, Inc.
  • Ticker: HRC
  • Exchange: NYSE
  • Founded: 1915
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$10.301b
  • Shares outstanding: 66.05m
  • Website: https://www.hillrom.com

Number of Employees


Location

  • Hill-Rom Holdings, Inc.
  • 130 East Randolph Street
  • Suite 1000
  • Chicago
  • Illinois
  • 60601
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/12/13 23:13
End of Day Share Price2021/12/10 00:00
Earnings2021/09/30
Annual Earnings2021/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.